| Activated ras Oncogenes in Human Thyroid Cancers NR Lemoine, ES Mayall, FS Wyllie, CJ Farr, D Hughes, RA Padua, ... Cancer research 48 (16), 4459-4463, 1988 | 323 | 1988 |
| FMS mutations in myelodysplastic, leukemic, and normal subjects. SA Ridge, M Worwood, D Oscier, A Jacobs, RA Padua Proceedings of the National Academy of Sciences 87 (4), 1377-1380, 1990 | 311 | 1990 |
| RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up RA Padua, BA Guinn, AI Al-Sabah, M Smith, C Taylor, T Pettersson, ... Leukemia 12 (6), 887-892, 1998 | 270 | 1998 |
| RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. RA Padua, G Carter, D Hughes, J Gow, C Farr, D Oscier, F McCormick, ... Leukemia 2 (8), 503-510, 1988 | 199 | 1988 |
| Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia? FV Rassool, TJ Gaymes, N Omidvar, N Brady, S Beurlet, M Pla, M Reboul, ... Cancer research 67 (18), 8762-8771, 2007 | 198 | 2007 |
| Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia J Holmes, A Jacobs, G Carter, A Janowska‐wieczorek, RA Padua British Journal of Haematology 72 (1), 40-44, 1989 | 173 | 1989 |
| A novel transforming gene in a human malignant melanoma cell line RA Padua, N Barrass, GA Currie Nature 311 (5987), 671-673, 1984 | 161 | 1984 |
| The molecular basis of myelodysplastic syndromes A Gallagher, RL Darley, RA Padua Haematologica 82 (2), 191-204, 1997 | 149 | 1997 |
| Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens AC Fan, D Deb-Basu, MW Orban, JR Gotlib, Y Natkunam, R O'neill, ... Nature medicine 15 (5), 566-571, 2009 | 132 | 2009 |
| Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis? TJ Gaymes, RA Padua, M Pla, S Orr, N Omidvar, C Chomienne, GJ Mufti, ... Molecular cancer research 4 (8), 563-573, 2006 | 122 | 2006 |
| Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies A Janowska-Wieczorek, AR Belch, A Jacobs, D Bowen, RA Padua, ... | 116 | 1991 |
| Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure RR West, DA Stafford, AD White, DT Bowen, RA Padua Blood, The Journal of the American Society of Hematology 95 (6), 2093-2097, 2000 | 114 | 2000 |
| Activation of N-ras in a human melanoma cell line RA Padua, NC Barrass, GA Currie Molecular and cellular biology, 1985 | 107 | 1985 |
| Frequent expression of HAGE in presentation chronic myeloid leukaemias SP Adams, SS Sahota, A Mijovic, B Czepulkowski, RA Padua, GJ Mufti, ... Leukemia 16 (11), 2238-2242, 2002 | 104 | 2002 |
| PML-RARA–targeted DNA vaccine induces protective immunity in a mouse model of leukemia RA Padua, J Larghero, M Robin, C Pogam, MH Schlageter, S Muszlak, ... Nature medicine 9 (11), 1413-1417, 2003 | 101 | 2003 |
| Clonal lymphocytes are detectable in only some cases of MDS DJ Culligan, P Cachia, J Whittaker, A Jacobs, RA Padua British journal of haematology 81 (3), 346-352, 1992 | 97 | 1992 |
| Multidrug resistance in leukaemia SL McKenna, RA Padua British journal of haematology 96 (4), 659-674, 1997 | 94 | 1997 |
| Mutant N-RAS Induces Erythroid Lineage Dysplasia in Human CD34+ Cells RL Darley, TG Hoy, P Baines, RA Padua, AK Burnett The Journal of experimental medicine 185 (7), 1337-1348, 1997 | 90 | 1997 |
| ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development. VK Shukla, DC Hughes, LE Hughes, F McCormick, RA Padua Oncogene Research 5 (2), 121-127, 1989 | 90 | 1989 |
| BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia N Omidvar, S Kogan, S Beurlet, C le Pogam, A Janin, R West, ... Cancer research 67 (24), 11657-11667, 2007 | 84 | 2007 |
